Online Inquiry

tRNA Purification Service

At GCEngine platform, high-purity tRNA is the cornerstone of reliable genetic code expansion. Every stage—from aminoacylation to ncAA incorporation—depends on tRNAs that are structurally intact, chemically clean, and free from contaminants. Our tRNA purification service delivers a comprehensive suite of purification technologies designed to isolate functional tRNAs from diverse sources, including synthetic transcripts, tagged constructs, and native biological systems. Each method is optimized to preserve folding, modifications, and aminoacylation capacity. As a result, purified tRNAs are compatible with precise orthogonal decoding and high translational fidelity in downstream assays.

Introduction to tRNA Purification

tRNA molecules (~70–80 nt) are small but chemically complex, containing numerous modifications that influence decoding accuracy and ribosomal engagement. During extraction or synthesis, contaminants such as rRNA, DNA, degraded fragments, or unprocessed precursors can co-purify, compromising tRNA functionality and quantification.

The GCEngine purification workflow combines size-based separation, sequence-specific capture, and native-state recovery techniques to obtain translationally active tRNAs suitable for downstream modification analysis, quality control, and ncAA incorporation experiments.

By tailoring purification strategies to the molecular source—gel-based isolation for precision, affinity-tag enrichment for selectivity, and native tRNA extraction for authenticity—the platform provides end-to-end tRNA purification aligned with research and preclinical applications.

tRNA purificationFig.1 Total tRNA fraction was gel-excised and purified. (Akiyama, Y., et al., 2020)

Our Services

Each tRNA Purification project under GCEngine follows a modular, source-dependent design. Synthetic tRNAs are purified for maximum recovery and modification preservation; affinity-tagged constructs are isolated for isoacceptor or variant specificity; and native tRNAs are extracted directly from prokaryotic or eukaryotic cells to retain their physiological modifications.

Gel-Based
tRNA Isolation

This service uses high-resolution denaturing polyacrylamide gel electrophoresis (PAGE) to separate tRNAs based on length and sequence-dependent electrophoretic behavior. In our internal benchmarks, the method typically achieves >95% purity for full-length mature tRNAs, as assessed by densitometry and analytical profiling. Following gel excision, RNA recovery is achieved via electroelution or diffusion under modification-preserving conditions.

Affinity-Tag
tRNA Isolation

Affinity purification enables selective capture of engineered or orthogonal tRNAs from complex mixtures. We support diverse tag systems, including biotin–streptavidin binding, antisense oligo hybridization, and EF-Tu-based enrichment for aminoacylated tRNAs. Each process is designed to preserve the molecule's native structure and aminoacylation site, followed by electrophoretic and functional validation.

Eukaryotic / Prokaryotic Native tRNA Purification

Native-source purification isolates physiologically modified tRNAs directly from bacterial or eukaryotic cells using optimized extraction and ion-exchange chromatography. Optional sequence-specific capture enriches desired isoacceptors while maintaining native modification patterns such as Ψ55, m¹A58, and s²U34. Each fraction is characterized by LC–MS/MS and electrophoresis to verify biological authenticity and structural integrity.

Contact Us

Purity drives precision. The GCEngine platform integrates advanced purification technologies to produce analytical-grade tRNAs—synthetic, engineered, or native—ready for orthogonal translation and ncAA incorporation. Contact us today to customize your tRNA purification workflow and secure translational accuracy across every step of genetic code expansion.

Reference

  1. Akiyama, Y., et al. (2020). Isolation and initial structure-functional characterization of endogenous tRNA-derived stress-induced RNAs. RNA biology, 17(8), 1116–1124.

All our services are exclusively intended for preclinical research purposes. They are not intended for diagnostic, therapeutic, or patient management applications.

Rare Skin Diseases

A specialized platform advancing genetic code expansion through orthogonal tRNA/aaRS technologies, enabling precise ncAA incorporation for biotherapeutic development, synthetic biology, and diagnostics.

USA

Denmark